Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

A woman has a permanent hair loss condition treated with steroids and new medicines, but hair might not regrow.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

The research found that different types of fibroblasts are involved in wound healing and that some blood cells can turn into fat cells during this process.

FFA's causes may include environmental triggers and genetic factors.

Syphilitic alopecia, linked to syphilis and high-risk sexual behavior, improves with penicillin treatment.

Intestinal stem cells can help repair skin damage from radiation.

Blocking interferon-gamma might help treat various autoimmune diseases.